Collplant Biotechnologies Stock Market Value
| CLGN Stock | USD 4.48 0.23 5.41% |
| Symbol | Collplant |
Collplant Biotechnologies Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Collplant Biotechnologies. If investors know Collplant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Collplant Biotechnologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.53) | Revenue Per Share 0.06 | Quarterly Revenue Growth (0.98) | Return On Assets (0.34) | Return On Equity (0.62) |
The market value of Collplant Biotechnologies is measured differently than its book value, which is the value of Collplant that is recorded on the company's balance sheet. Investors also form their own opinion of Collplant Biotechnologies' value that differs from its market value or its book value, called intrinsic value, which is Collplant Biotechnologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Collplant Biotechnologies' market value can be influenced by many factors that don't directly affect Collplant Biotechnologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Collplant Biotechnologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Collplant Biotechnologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Collplant Biotechnologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Collplant Biotechnologies 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Collplant Biotechnologies' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Collplant Biotechnologies.
| 06/03/2024 |
| 11/30/2024 |
If you would invest 0.00 in Collplant Biotechnologies on June 3, 2024 and sell it all today you would earn a total of 0.00 from holding Collplant Biotechnologies or generate 0.0% return on investment in Collplant Biotechnologies over 180 days. Collplant Biotechnologies is related to or competes with Keros Therapeutics, Merus BV, Vericel Corp, Century Therapeutics, Shattuck Labs, C4 Therapeutics, and Eliem Therapeutics. CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional bioprinting ... More
Collplant Biotechnologies Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Collplant Biotechnologies' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Collplant Biotechnologies upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.11) | |||
| Maximum Drawdown | 14.36 | |||
| Value At Risk | (5.10) | |||
| Potential Upside | 4.69 |
Collplant Biotechnologies Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Collplant Biotechnologies' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Collplant Biotechnologies' standard deviation. In reality, there are many statistical measures that can use Collplant Biotechnologies historical prices to predict the future Collplant Biotechnologies' volatility.| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.26) | |||
| Total Risk Alpha | (0.78) | |||
| Treynor Ratio | (1.11) |
Collplant Biotechnologies Backtested Returns
Collplant Biotechnologies secures Sharpe Ratio (or Efficiency) of -0.0881, which signifies that the company had a -0.0881% return per unit of risk over the last 3 months. Collplant Biotechnologies exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Collplant Biotechnologies' Risk Adjusted Performance of (0.05), mean deviation of 2.43, and Standard Deviation of 3.25 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.21, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Collplant Biotechnologies' returns are expected to increase less than the market. However, during the bear market, the loss of holding Collplant Biotechnologies is expected to be smaller as well. At this point, Collplant Biotechnologies has a negative expected return of -0.29%. Please make sure to confirm Collplant Biotechnologies' kurtosis, and the relationship between the maximum drawdown and day median price , to decide if Collplant Biotechnologies performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.72 |
Good predictability
Collplant Biotechnologies has good predictability. Overlapping area represents the amount of predictability between Collplant Biotechnologies time series from 3rd of June 2024 to 1st of September 2024 and 1st of September 2024 to 30th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Collplant Biotechnologies price movement. The serial correlation of 0.72 indicates that around 72.0% of current Collplant Biotechnologies price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.72 | |
| Spearman Rank Test | 0.32 | |
| Residual Average | 0.0 | |
| Price Variance | 0.22 |
Collplant Biotechnologies lagged returns against current returns
Autocorrelation, which is Collplant Biotechnologies stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Collplant Biotechnologies' stock expected returns. We can calculate the autocorrelation of Collplant Biotechnologies returns to help us make a trade decision. For example, suppose you find that Collplant Biotechnologies has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Collplant Biotechnologies regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Collplant Biotechnologies stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Collplant Biotechnologies stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Collplant Biotechnologies stock over time.
Current vs Lagged Prices |
| Timeline |
Collplant Biotechnologies Lagged Returns
When evaluating Collplant Biotechnologies' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Collplant Biotechnologies stock have on its future price. Collplant Biotechnologies autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Collplant Biotechnologies autocorrelation shows the relationship between Collplant Biotechnologies stock current value and its past values and can show if there is a momentum factor associated with investing in Collplant Biotechnologies.
Regressed Prices |
| Timeline |
Pair Trading with Collplant Biotechnologies
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Collplant Biotechnologies position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Collplant Biotechnologies will appreciate offsetting losses from the drop in the long position's value.Moving together with Collplant Stock
Moving against Collplant Stock
| 0.88 | EWTX | Edgewise Therapeutics | PairCorr |
| 0.86 | GILD | Gilead Sciences | PairCorr |
| 0.8 | BHC | Bausch Health Companies | PairCorr |
| 0.74 | GANX | Gain Therapeutics | PairCorr |
| 0.69 | BMY | Bristol Myers Squibb Sell-off Trend | PairCorr |
The ability to find closely correlated positions to Collplant Biotechnologies could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Collplant Biotechnologies when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Collplant Biotechnologies - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Collplant Biotechnologies to buy it.
The correlation of Collplant Biotechnologies is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Collplant Biotechnologies moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Collplant Biotechnologies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Collplant Biotechnologies can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Collplant Biotechnologies Correlation, Collplant Biotechnologies Volatility and Collplant Biotechnologies Alpha and Beta module to complement your research on Collplant Biotechnologies. To learn how to invest in Collplant Stock, please use our How to Invest in Collplant Biotechnologies guide.You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Collplant Biotechnologies technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.